Skip to content

New drug data makes this French biotech stock a buy, says Jefferies · Stateside Daily

Stateside DailyAll America

Search Get alerts

Home›Business›1 sources

Business · 1 sources covering this

New drug data makes this French biotech stock a buy, says Jefferies

Analyst Faisal Khurshid upgraded the stock to buy from hold.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
New drug data makes this French biotech stock a buy, says Jefferies
Analyst Faisal Khurshid upgraded the stock to buy from hold.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/54766b7a47ca81ec7153ea778d0f86df056fa91c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="New drug data makes this French biotech stock a buy, says Jefferies"></iframe>

More from Business

CBS NewsLean L·27m ago

This number helps explain why many Americans are down on the economy

CNBCLean R·30m ago

Buy the UK DIP? Defense stocks lifted by $20 billion spending boost as gilts come under fire

Daily briefing

Stateside Daily in your inbox

The 5 stories from all america you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Stateside Daily

About
Methodology
Sources
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets

CNBCLean R·33m ago

Oil prices wobble as uncertainty persists over U.S.-Iran talks in Qatar

CNBCLean R·41m ago

Kroger to buy Giant Eagle in $1.65 billion deal

Reader

Today's briefing
Archive
Topics
Editorial guides
Notifications
Embed widgets
Bookmarks
Search

Trust & legal

Coverage stats
Corrections
Privacy
Terms
Security

Across the network

Hindustan Sphere
All India in one feed

© 2026 Stateside Daily. All headlines are sourced from third-party publishers; we never republish article bodies.

All America